Cellebrite DI Ltd. (CLBT) P/E Ratio History
Fairly ValuedTrading at 35.7x, near 5Y avg of 36.6x · 45th percentile · In line with own history · Data 2021–2026
Loading P/E history...
P/E Ratio Analysis
As of October 3, 2026, Cellebrite DI Ltd. (CLBT) trades at a price-to-earnings ratio of 35.7x, with a stock price of $11.07 and trailing twelve-month earnings per share of $0.23.
The current P/E is roughly in line with its 5-year average of 36.6x. Over the past five years, CLBT's P/E has ranged from a low of 4.7x to a high of 73.0x, placing the current valuation at the 45th percentile of its historical range.
Compared to the Technology sector median P/E of 29.4x, CLBT trades at a 21% premium to its sector peers. The sector includes 363 companies with P/E ratios ranging from 0.0x to 197.7x.
Relative to the broader market, CLBT commands a significant premium over the S&P 500 median P/E of 24.5x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CLBT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CLBT Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
CLBT P/E vs Peers
Data platforms, integration and analytics peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $33B | 273.7 | - | -69% | |
| $672M | 9.5Lowest | - | +30% | |
| $3B | 31.5 | 0.83 | +126%Best | |
| $341M | 25.5 | - | -88% | |
| $3B | 33.5 | 2.34 | +21% | |
| $14B | 25.5 | 4.46 | +8% | |
| $5B | 16.3 | 0.98 | +7% | |
| $15B | 10.6 | 0.51Best | +21% | |
| $8B | 9.7 | 1.02 | -5% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
CLBT Historical P/E Data (2021–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | - | $14.60 | $0.23 | 62.4x | +70% |
| FY2026 Q1 | - | $13.78 | $0.29 | 48.0x | +31% |
| FY2025 Q4 | Dec 31 2025 | $18.03 | $0.31 | 57.5x | +57% |
| FY2025 Q3 | - | $18.53 | $0.31 | 60.4x | +65% |
| FY2023 Q1 | Mar 31 2023 | $6.09 | $0.12 | 50.8x | +38% |
| FY2022 Q4 | Dec 31 2022 | $4.36 | $0.62 | 7.0x | -81% |
| FY2022 Q3 | Sep 30 2022 | $3.92 | $0.83 | 4.7x | -87% |
| FY2022 Q2 | - | $5.10 | $0.75 | 6.8x | -81% |
| FY2022 Q1 | - | $6.40 | $0.62 | 10.3x | -72% |
| FY2021 Q4 | Dec 31 2021 | $8.02 | $0.36 | 22.2x | -39% |
| FY2021 Q3 | - | $9.26 | $0.13 | 73.0x | +99% |
Average P/E for displayed period: 36.6x
CLBT Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CLBT — Frequently Asked Questions
Quick answers to the most common questions about buying CLBT stock.
What is CLBT's P/E ratio?
Cellebrite DI Ltd. (CLBT) trailing twelve-month P/E ratio is 35.7x, based on TTM diluted EPS of $0.23. The 5-year average P/E is 36.6x and the historical range spans 4.7x to 73.0x.
Is CLBT stock overvalued or undervalued?
CLBT trades at 35.7x P/E, near its 5-year average of 36.6x. The 45th percentile ranking within the 4.7x–73.0x historical range places valuation within normal bounds.
Is CLBT stock expensive?
CLBT is fairly valued relative to its own history. The current P/E of 35.7x is near the 5-year average of 36.6x (45th percentile of historical range).
What is CLBT's historical P/E range?
Over the past 5 years, CLBT's P/E ratio has ranged from 4.7x to 73.0x, with a median of 48.0x and an average of 36.6x. The current P/E of 35.7x places the stock at the 45th percentile of this range. Full historical data spans 2021–2026.
How does CLBT's P/E compare to the S&P 500?
CLBT trades at 35.7x P/E versus the S&P 500 median of 24.5x. The 46% premium to the market typically reflects higher expected earnings growth or quality.
How does CLBT's valuation compare to Technology peers?
Cellebrite DI Ltd. P/E of 35.7x compares to the Technology sector median of 29.4x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is CLBT's PEG ratio?
CLBT PEG ratio is N/A, based on a P/E of 35.7x and EPS growth of 123.0%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is CLBT's earnings yield?
CLBT earnings yield is 2.80%, the inverse of its 35.7x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.